Uflex Ltd Q4 FY2022 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/u42gjup7w77i9iko80a58qwp.pdf

Key Takeaways


Aseptic Packaging: The Growth Engine

Rajesh Bhatia: "You are right. Great idea. I think we can, we will definitely discuss internally, if there is a merit in this and there's a value to be taken, why not?"

Raw Material Margin Mechanics

Rajesh Bhatia: "In the packaging though, still there is a lag there from a months or going maximum up to three months basis. So that lag is going to affect your margins as the raw material prices go up. ... I have no qualms about not admitting that."

Geopolitical Exposure: Russia and Eastern Europe

Rajesh Bhatia: "There have been only a positive impact on the Russia business, per say."

Capital Allocation and Leverage

Rajesh Bhatia: "We don't want to become net debts zero company. I think that's the most inefficient way to grow your business."

Demand Resilience and Customer Dynamics

Rajesh Bhatia: "95% of my business is packaging foods, which is the basic necessity for life. So, you know, given that the food and you know, we don't do any fancy food stuffs and all that, we are just the primary packing of the food is our core business. So there, you know, frankly, we don't see any impacts of you know, recession coming and affecting us"

Regulatory and Sustainability Positioning


Guidance & Commitments

CommitmentSpecificsTimeline
Nigeria recoverySupply chain bottlenecks sorted, better numbers expectedNext 1-2 quarters
Aseptic packaging growthGood numbers expected given 86% utilization and expanded facility rampingFY23
Dharwad and Dubai contributionAdditional revenues and profitability as facilities commissionFY22 (commissioning)
Flex Middle East listing readinessAbsolute readiness for filing expectedCurrent quarter (Q1 FY23)
Paper straw complianceMore machines being added; prepared for any deadline extensionNext six months (partial by 1st July 2022)
Debt trajectoryFrom ~₹4,000 crores net debt to ~₹3,000 crores via amortization and limited new capexOver next two years
PET chips project returnConservative IRR of close to 19%Project lifetime

Key Metrics

MetricQ4 FY22
RevenueAlmost ₹4,000 cr, quarterly record
FY22 revenue₹13,225 cr, up ~49% YoY
FY22 volume growth~30% in both packaging film and packaging business
Q4 EBITDA₹734 cr, quarterly highest ever
FY22 EBITDA₹2,804 cr, up ~25% YoY, highest ever
FY22 EBITDA margin17.24%, vs 20.5% last year; ~20% when neutralizing raw material impact per management
FY22 PAT₹1,098 cr, up 30% YoY
Egypt currency devaluation impact₹38 cr exceptional item, from 16% devaluation of Egyptian pound on 21st March
Net debt₹3,974 cr, up ~₹600 cr vs March 21
Net debt to EBITDA1.74x
Long-term debt~₹3,500 cr
Short-term debt~₹1,000 cr
Cash on balance sheet~₹600 cr
DividendUp ~30% for the year
Dividend payout ratio2% in March 2022, declined from 9% in FY14 (per an analyst's math)
Aseptic packaging capacity utilization86% in FY22, vs 55% last year
Aseptic packaging annual growth rate18–20%
Asepto capacity700 cr packs
Asepto capacity utilization (recent)90% reached
Asepto margin guidance18–22%
Packaging films share of top line60–65%
International business share60–65%
ROCE16%
Borrowing cost (euros/dollars)1–2% spreads
Next year amortization~₹500 cr
New capex announced~₹580 cr
PET chips project IRR~19%